MarketsandMarkets Blog

The global liquid biopsy market is projected to reach USD 10.0 billion by 2027 from USD 4.3 billion in 2022, at a CAGR of 18.3% during the forecast period. Growth in the liquid biopsy market is mainly driven by factors such as the rising incidence and prevalence of cancer, awareness initiatives undertaken by global health organizations, and the increasing preference for noninvasive treatment procedures....

Liquid biopsy is a non-invasive diagnostic technique that involves the detection of cancer biomarkers in the blood or other bodily fluids. It is a rapidly growing field, with the potential to revolutionize cancer diagnosis and treatment. In this blog, we will explore the liquid biopsy industry, its market size, and trends, as well as the factors driving the growth of the industry.Market Size and TrendsThe...

Introduction to Liquid BiopsyLiquid biopsy is a non-invasive procedure which uses a sample of a patient’s blood to detect cancer cells. This can be used to monitor the progression of a disease and to detect genetic changes that may be associated with the disease. It is a relatively new technique which is being used to identify early markers of cancer and to provide more information about the...

The increasing preference for noninvasive treatment procedures, the rising incidence and prevalence of cancer, and awareness initiatives undertaken by global health organizations are the major factors driving the liquid biopsy market growth. According to research report the global liquid biopsy market size is projected to reach $5.8 billion by 2026 from $2.5 billion in 2021, at a CAGR of 18.1%...

Liquid Biopsy Market is projected to reach USD 5.8 billion by 2026 from USD 2.5 billion in 2021, at a CAGR of 18.1% according to a new report by MarketsandMarkets™. The rising incidence and prevalence of cancer and the increasing preference for noninvasive treatment procedures are among the major factors propelling the growth of this market. Emerging economies such as China, Japan, and...

The increasing preference for noninvasive treatment procedures, the rising incidence and prevalence of cancer, and awareness initiatives undertaken by global health organizations are the major factors driving the liquid biopsy market growth. According to research report the global liquid biopsy market size is projected to reach $5.8 billion by 2026 from $2.5 billion in 2021, at a CAGR of 18.1%...

Market growth due to rising incidence and prevalence of cancer and the increasing preference for noninvasive treatment procedures these factors propelling the growth of this market. Emerging economies such as China, Japan, and India are providing lucrative opportunities for the players operating in the Liquid Biopsy Market. According to the new market research report global liquid biopsy...

According to the new market research report Liquid Biopsy Market by Product (Assay Kits, Instruments, Service), Circulating Biomarkers (CTC, ctDNA), Technology (NGS, PCR), Application (Cancer (Lung, Breast, Prostate), Non-Cancer), End User (Reference Lab, Hospitals) – Global Forecast to 2026, published by MarketsandMarkets™, the global market is projected to reach USD 5.8 billion by 2026...